The Drug Repurposing (DR) portal, an initiative of Excelra, is an on-demand news channel that focuses on the latest news, breakthroughs, events, and conferences in the realm of drug repurposing and repositioning. With heavy investments made in developing and commercializing a new drug, a process often hit by high drug attrition rates, only 1 out of 10 drugs see the light of the day. As a consequence DR holds immense promise in expanding the therapeutic utility of pre-existing or failed, abandoned drugs. In order to promote the significance of DR among a wider scientific and pharma audience, Excelra endeavours to share current happenings in DR through this portal.
The DR portal aspires to become a hub not only to view and access information, but also for creating opportunities for everyone to share articles, breakthroughs, and any events related to DR. A curated database of repurposed drugs with original and corresponding alternate indication(s) forms an integral part of this portal, and Excelra provides an opportunity to folks who would like to submit any information related to newly approved repurposed drugs into this database.
So, read on and keep yourself abreast of all that is new, and also subscribe to the DR newsletter to get a glimpse of what’s new in drug repurposing.